1. Home
  2. Labeler Index
  3. Cipla Usa Inc.
  4. 69097-880
  5. NDC Package Code: 69097-880-67 Lanreotide Acetate

NDC Package 69097-880-67 Lanreotide Acetate

Injection Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
69097-880-67
Package Description:
1 SYRINGE in 1 CARTON / .2 mL in 1 SYRINGE
Product Code:
69097-880
Proprietary Name:
Lanreotide Acetate
Non-Proprietary Name:
Lanreotide Acetate
Substance Name:
Lanreotide Acetate
Usage Information:
This medication is a long-acting form of lanreotide. Lanreotide is used to treat a condition called acromegaly that occurs when the body makes too much of a certain natural substance called growth hormone. It is used when surgery or radiation treatment have not been fully successful or cannot be used. Treating acromegaly helps reduce the risk of serious problems such as diabetes and heart disease. Lanreotide works by decreasing the amount of growth hormone to normal levels. This drug is not a cure for acromegaly. It is used for the long-term treatment of this condition. This medication is also used to treat certain cancer or tumors of the stomach, intestines, or pancreas. It may help to slow down the growth of these tumors. Lanreotide is also used to treat carcinoid syndrome. It may help reduce the need to use another medication to treat diarrhea or flushing caused by carcinoid syndrome.
11-Digit NDC Billing Format:
69097088067
NDC to RxNorm Crosswalk:
  • RxCUI: 749811 - lanreotide 60 MG in 0.2 ML Prefilled Syringe
  • RxCUI: 749811 - 0.2 ML lanreotide 300 MG/ML Prefilled Syringe
  • RxCUI: 749811 - lanreotide 60 MG per 0.2 ML (as lanreotide acetate) Prefilled Syringe
  • RxCUI: 749814 - lanreotide 120 MG in 0.5 ML Prefilled Syringe
  • RxCUI: 749814 - 0.5 ML lanreotide 240 MG/ML Prefilled Syringe
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Cipla Usa Inc.
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
    • Active Ingredient(s):
  • LANREOTIDE ACETATE 60 mg/.2mL
    • Pharmacologic Class(es):
  • Somatostatin Analog - [EPC] (Established Pharmacologic Class)
  • Somatostatin Receptor Agonists - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    NDA215395
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    12-24-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 69097-880-67?

    The NDC Packaged Code 69097-880-67 is assigned to a package of 1 syringe in 1 carton / .2 ml in 1 syringe of Lanreotide Acetate, a human prescription drug labeled by Cipla Usa Inc.. The product's dosage form is injection and is administered via subcutaneous form.

    Is NDC 69097-880 included in the NDC Directory?

    Yes, Lanreotide Acetate with product code 69097-880 is active and included in the NDC Directory. The product was first marketed by Cipla Usa Inc. on December 24, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 69097-880-67?

    The 11-digit format is 69097088067. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-269097-880-675-4-269097-0880-67